相关实验视频

Updated: Jul 13, 2026

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

基于多种机器学习方法,开发与胰腺癌患者药物耐药性相关的预后标志物

Song Xu¹, Chuanmin Deng², Zhongran Man²

¹Department of Hepatobiliary Surgery, Shangyu People's Hospital of Shaoxing, Shaoxing University,Shaoxing, Zhejiang, China.

Annals of medicine and surgery (2012)

|December 11, 2025

概括

这项研究确定了胰腺腺癌 (PAAD) 中的12个关键耐药基因,揭示了与患者风险相关的免疫差异. 这些发现为向免疫治疗提供了新的途径,以改善PAAD治疗策略.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
免疫学免疫学免疫学

背景情况:

胰腺腺癌 (PAAD) 由于耐药性而带来重大治疗挑战.
识别新的预后生物标志物对于开发有效的治疗策略至关重要.

研究的目的:

通过分析药物耐药性表型来确定PAAD的新型预后生物标志物和治疗策略.
开发和验证一个强大的预后模型,使用多omics数据和机器学习.

主要方法:

来自公共数据库的综合多主题数据 (测序,临床,基因组)
使用ssGSEA计算了样本抗性得分,并进行了生存分析.
开发并验证了一个使用机器学习算法的预后模型,包括随机生存森林.

主要成果:

在多个数据集中确定了12个与PAAD预后一致相关的基因.
高风险组在细胞循环和全身性红斑狼途径中丰富;低风险组在神经活性联体受体相互作用中.
观察到显著的免疫细胞透差异:高风险组活化CD8+T细胞较低,调节性T细胞较高.
随机生存森林模型显示出强大的预测性能 (C指数=0.634,1,2,3年的AUC:0.973,0.978,0.996).

结论:

在PAAD中确定了12个关键的耐药基因.
突出了风险组之间的显著免疫微环境差异.
研究结果支持针对性免疫疗法研究,以改善PAAD治疗策略.

关键词:

生物标志物生物标志物药物耐药性耐药性药物耐药性机器学习是机器学习.胰腺癌是一种癌症.

更多相关视频

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...